Press release
Osteoporosis Drugs Market Analysis 2024-2031 | Leading Companies, Pipeline Drugs & Outlook By DataM intelligence Report
Osteoporosis Drugs Market
The Osteoporosis Drugs Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data analysis with expert insights. At DataM Intelligence, we simplify complex market dynamics into actionable strategies-empowering businesses to remain competitive, scale confidently, and capitalize on the right opportunities in an ever-evolving landscape.
Unlock exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://datamintelligence.com/download-sample/osteoporosis-drugs-market?kb
Osteoporosis Drugs Market Overview
Osteoporosis drugs are medications used to prevent, treat, or manage osteoporosis, a condition characterized by weakened bones and an increased risk of fractures. These drugs work by either slowing down bone loss, increasing bone formation, or strengthening existing bone mass to reduce the risk of fractures, especially in the spine, hips, and wrists.
Research Methodology:
The global Osteoporosis Drugs Market research report is based on a combination of primary and secondary data sources. The study carefully analyzes various factors influencing the industry, including government regulations, market dynamics, competitive landscape, historical trends, current conditions, and technological progress. It also evaluates future developments, related industry trends, market volatility, growth prospects, potential obstacles, and emerging challenges.
Segment Covered in the Osteoporosis Drugs Market:
By Drug Class: Bisphosphonates, RANK Ligand Inhibitors, Selective Estrogen Receptor Modulators, Parathyroid Hormone Analog, Strontium, Calcitonin, Anti-Sclerostin, and Cathepsin K Inhibitor
By Product Type: Branded and Generics
By Distribution Channel: Hospital Pharmacy, Retail Pharmacy and Other
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/osteoporosis-drugs-market?kb
List of the Key Players in the Osteoporosis Drugs Market:
F. Hoffmann-La Roche, Novartis AG, Merck & Co, Pfizer, Eli Lilly and Co. (Lilly), Amgen Inc., Radius Health, Teva Pharmaceutical Industries, GSK and AbbVie among others.
Industry Development:
In May 2023, Transcenta Holding Limited-a clinical-stage biopharmaceutical company with end-to-end capabilities in antibody-based therapeutic development-shared promising Phase I clinical data for TST002 (Blosozumab) in Chinese patients with low bone mineral density (BMD). A single intravenous dose of TST002 led to a significant increase in BMD by day 85 and was well tolerated across all tested doses.
Also in May 2023, new real-world evidence from a U.S. Medicare study involving nearly 500,000 postmenopausal women with osteoporosis revealed that Prolia (denosumab) was more effective at reducing fracture risk than oral alendronate, a commonly prescribed bisphosphonate. Over time, Prolia use was consistently associated with a notable reduction in fracture incidence.
Regional Analysis for Osteoporosis Drugs Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
The Report Includes:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.
People Also Ask:
➠ What are the global sales, production, consumption, imports, and exports in the Osteoporosis Drugs market?
➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?
➠ What key opportunities and challenges do vendors face in the Osteoporosis Drugs industry?
➠ Which product types, applications, or end-users are driving market growth, and what is their market share?
➠ What are the major growth drivers and restraints of the Osteoporosis Drugs market?
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Osteoporosis Drugs Market Analysis 2024-2031 | Leading Companies, Pipeline Drugs & Outlook By DataM intelligence Report here
News-ID: 4084816 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Global Nuclear Imaging Market | SPECT & PET Technologies Transform Disease Detec …
Global Nuclear Imaging Market is expected grow at a CAGR of 12.9% during the forecast period 2024-2031
The Nuclear Imaging Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their innovative product offerings, competitive pricing strategies, financial performance metrics, strategic growth plans, and regional market…
Global Radiology Information System Market Size, Share, Growth Drivers & Leading …
The Global Radiology Information System Market reached US$ 1.30 billion in 2024 and is expected to reach US$ 3.02 billion by 2033, growing at a CAGR of 7.6% during the forecast period 2025-2033.
The Radiology Information System Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data analysis with expert…
Next Generation Biometrics Market Predicted to Reach US$ 93.8 billion by 2030 | …
Next Generation Biometrics Market reached US$ 42.7 billion in 2022 and is expected to reach US$ 93.8 billion by 2030, growing with a CAGR of 17.5% during the forecast period 2024-2031.
The Next Generation Biometrics Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay…
Global Macular Edema Market | Anti-VEGF and Steroid Therapies Lead | Most Leadin …
The Global Macular Edema Market reached US$ 7,932.69 million in 2023 and is expected to reach US$ 14,874.70 million by 2031, growing at a CAGR of 8.4% during the forecast period 2024-2031.
The Macular Edema Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their…
More Releases for Osteoporosis
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Osteoporosis Drugs Market : Rising prevalence of osteoporosis and aging populati …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Bone Densitometry Scan for Osteoporosis & Osteopenia
Global Bone Densitometers Market: Snapshot
Of late, the global bone densitometers market has been registering a phenomenal increase in its size and valuation. The significant rise in the pool of patients suffering from arthritis and vitamin D deficiency, supported by the surge in the geriatric population across the world, have influenced this market substantially. The increasing prevalence of osteoporosis in post-menopausal women is also contributing considerably to the growth of…
2022 Osteoporosis Drugs Market Analysis & Forecast
Global Osteoporosis Drugs Market Information, by drug class (Bisphosphonates, Calcitonins, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone (PTH) and Others), by route of administration (oral, injectable and others) and by gender (male and female) - Forecast to 2022
The Global Osteoporosis Market to reach 14,300 million by 2022, growing with a CAGR of 4.7%.
Osteoporosis is weakening of bones due to lower bone mass resulting in and micro-architectural deterioration of bone…
Datamonitor Healthcare Osteoporosis KOL Interviews
ReportsWorldwide has announced the addition of a new report title Datamonitor Healthcare Osteoporosis KOL Interviews to its growing collection of premium market research reports.
For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/datamonitor-healthcare-osteoporosis-kol-interviews
February 03, 2017
Datamonitor Healthcare interviewed an endocrinologist based in the US and a rheumatologist based in the UK to gauge their views on current treatment options, late stage clinical candidates, treatment challenges…
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related…
